VILDAPIN PLUS 850 is a fixed-dose combination of Vildagliptin, a DPP-4 inhibitor, and Metformin Hydrochloride, a biguanide, used for the effective management of Type 2 Diabetes Mellitus in adults. This dual-action therapy helps improve glycemic control by enhancing insulin secretion, reducing hepatic glucose production, and improving insulin sensitivity without causing significant weight gain or hypoglycemia.